Expert Perspectives on the VIOLETTE Study and Future Directions in Prostate Cancer Research
Amir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.
Integrating MRI and Ultrasound Fusion-Based Technology for Personalized Focal Therapy in Prostate Cancer
Dr. Amir H. Lebastchi elaborates on his approach to integrating MRI and ultrasound fusion-based technology for guiding treatment selection and tailoring therapy for patients with prostate cancer.
Leveraging MRI and Fusion-Guided Biopsy for Active Surveillance in Prostate Cancer
Amir H. Lebastchi, MD, outlines his general strategy for active surveillance in prostate cancer patients, emphasizing the role of MRI and fusion-guided prostate biopsy.
Perspectives on Comparative Data for Software- and Cognitive-Based Fusion Biopsies
Dr. Amir H. Lebastchi reviews retrospective data comparing software-based and cognitive-based fusion biopsy approaches, providing valuable insights into the findings.
The Evolving Landscape Surrounding Fusion-Guided Prostate Biopsy
Amir H. Lebastchi, MD, explores the evolving landscape in the context of fusion-guided prostate biopsy methods.
Updates in Approaches for Prostate Cancer Biopsy and Diagnosis
Dr Amir H. Lebastchi delves into the latest advancements and evolving tactics in the field of prostate cancer biopsy and diagnostic procedures.
Landscape Surrounding Prostate Cancer Screening
Amir H. Lebastchi, MD, provides insights into the current prostate cancer landscape, emphasizing the importance of prostate cancer screening and early detection.
MRI/TRUS fusion-guided biopsy using UroNav
Pinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
2 Commerce Drive Cranbury, NJ 08512